Summit Therapeutics, Inc.
Associate Director, Clinical Operations
Summit Therapeutics, Inc., Menlo Park, California, United States, 94029
Associate Director, Clinical Operations – Summit Therapeutics, Inc.
Join to apply for the
Associate Director, Clinical Operations
role at
Summit Therapeutics, Inc.
About Summit Ivonescimab, known as SMT112, is a novel, potential first‑in‑class investigational bispecific antibody combining the effects of immunotherapy via a blockade of PD‑1 with the anti‑angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooperative binding to each of its intended targets with multifold higher affinity when in the presence of both PD‑1 and VEGF.
Summit has begun its clinical development of ivonescimab in non‑small cell lung cancer (NSCLC), with three active Phase III trials:
HARMONi is a Phase III clinical trial which intends to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR‑mutated, locally advanced or metastatic non‑squamous NSCLC who have progressed after treatment with a 3rd generation EGFR TKI (e.g., osimertinib).
HARMONi‑3 is a Phase III clinical trial which is designed to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first‑line metastatic NSCLC.
HARMONi‑7 is a Phase III clinical trial which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first‑line metastatic NSCLC whose tumors have high PD‑L1 expression.
Ivonescimab is an investigational therapy that is not approved by any regulatory authority in Summit’s license territories, including the United States and Europe. Ivonescimab was approved for marketing authorization in China in May 2024. Ivonescimab was granted Fast‑Track designation by the US Food & Drug Administration (FDA) for the HARMONi clinical trial setting.
Overview of Role The Associate Director, Clinical Operations is a highly autonomous and experienced clinical operations professional responsible for all aspects of Clinical Trial Management for global studies. This position is responsible for study start‑up and maintenance through study close‑out. The Associate Director, Clinical Operations will coordinate, lead, and drive Summit’s cross‑functional team members, CROs, and vendors to successfully deliver clinical studies. They will be responsible for all performance metrics and quality of deliverables in the clinical trial.
Role and Responsibilities
Oversee study scope, quality, timelines, and budget with internal Summit functional leads, CROs, and vendors to ensure that overall project objectives are met.
Foster solid professional relationships with key opinion leaders and clinical site staff.
Partner with CRO(s) to ensure robust patient enrollment strategies are developed and carried out effectively and on time.
Partner with CRO(s) to ensure robust ongoing data monitoring strategies are developed and carried out effectively to ensure delivery of high‑quality data.
Proactively identify and manage study related risks.
Responsible for the development and management of clinical trial documents including protocols, case report forms (CRFs), consent documents, confidentiality agreements.
Review and manage study related plans, processes including investigator agreements (CTA), CRFs, CRF guidelines, statistical / pharmacokinetic analysis plans, monitoring plan, data management, and safety monitoring.
Review CRO(s) and vendor contracts/work orders and specifications to enable study objectives to be met.
Review and approve essential document packages to enable timely site activations.
Review pre‑study, study initiation, interim monitoring visit and at study closeout visit reports.
Provide close oversight on the findings on the monitoring reports and loop back with broader team to provide updates.
Direct investigator performance and adherence to protocol, and proactively address conduct issues and enrollment problems, as necessary.
Responsible for oversight of the maintenance of the TMF and completeness at the end of the study.
Perform periodic QC of the TMF.
Oversee the creation and execution of clinical trial activities in accordance with Good Clinical Practices (GCP).
Ensure compliance of clinical trials with national and international regulatory requirements and co‑monitor the assigned clinical trial following company SOPs.
Ensure the study is “inspection ready” always.
Responsible for oversight and coaching of functional activities of Clinical Research Associates and Clinical Trial Associates allocated to the project.
Perform other duties as assigned.
Experience, Education and Specialized Knowledge and Skills
Bachelor’s degree or equivalent in life science, nursing, pharmacy, medical laboratory technology, or other health/medical related area preferred.
10+ years of clinical project management experience in conducting international clinical trials in sponsor Pharma/Biotech organization.
A minimum of 5+ years of phase II and III combined experience required.
Strong understanding of the drug development process, ICH guidelines/GCP and specifically, each step within the clinical trial process.
Experience with budget forecasting and management.
Experience with clinical studies in oncology strongly preferred.
Ability to travel internationally to visit clinical sites and for study meetings (up to 20%).
Proven proficiency in overseeing large complex studies being managed in house and by a CRO.
Demonstrated ability to lead teams and work in a fast‑paced team environment.
Line management (direct reports) experience preferred.
Demonstrated ability to effectively delegate and manage others, as evidenced through either past people management or matrix management responsibilities.
Proven track record of building relationships with KOLs and site personnel.
Ability to successfully engage and work collaboratively with overseas clinical operations team members/colleagues.
Demonstrated ability to build and deliver on patient enrollment strategies.
Excellent interpersonal and decision‑making skills. Demonstrates innovation, possesses drive, energy, and enthusiasm to deliver the program objectives.
Demonstrated ability to comprehend and communicate complex scientific concepts and data.
Proficient in reviewing and assessing clinical data.
Possesses excellent planning, time management & coordination skills.
Demonstrated ability to problem solve and use clear judgment in relation to regulatory requirements, interactions with external parties, timelines, and complex clinical programs.
Proficient user of standard MS Office suite (e.g., Word, Excel), experience using electronic document management systems, and document review tools desirable.
Strong attention to detail, accuracy and confidentiality.
Must be able to effectively multi‑task and manage time‑sensitive and highly confidential documents.
Compensation The pay range for this role is $168,000–$198,000 annually. Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.
Contact Recruiting@smmttx.com
#J-18808-Ljbffr
Associate Director, Clinical Operations
role at
Summit Therapeutics, Inc.
About Summit Ivonescimab, known as SMT112, is a novel, potential first‑in‑class investigational bispecific antibody combining the effects of immunotherapy via a blockade of PD‑1 with the anti‑angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooperative binding to each of its intended targets with multifold higher affinity when in the presence of both PD‑1 and VEGF.
Summit has begun its clinical development of ivonescimab in non‑small cell lung cancer (NSCLC), with three active Phase III trials:
HARMONi is a Phase III clinical trial which intends to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR‑mutated, locally advanced or metastatic non‑squamous NSCLC who have progressed after treatment with a 3rd generation EGFR TKI (e.g., osimertinib).
HARMONi‑3 is a Phase III clinical trial which is designed to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first‑line metastatic NSCLC.
HARMONi‑7 is a Phase III clinical trial which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first‑line metastatic NSCLC whose tumors have high PD‑L1 expression.
Ivonescimab is an investigational therapy that is not approved by any regulatory authority in Summit’s license territories, including the United States and Europe. Ivonescimab was approved for marketing authorization in China in May 2024. Ivonescimab was granted Fast‑Track designation by the US Food & Drug Administration (FDA) for the HARMONi clinical trial setting.
Overview of Role The Associate Director, Clinical Operations is a highly autonomous and experienced clinical operations professional responsible for all aspects of Clinical Trial Management for global studies. This position is responsible for study start‑up and maintenance through study close‑out. The Associate Director, Clinical Operations will coordinate, lead, and drive Summit’s cross‑functional team members, CROs, and vendors to successfully deliver clinical studies. They will be responsible for all performance metrics and quality of deliverables in the clinical trial.
Role and Responsibilities
Oversee study scope, quality, timelines, and budget with internal Summit functional leads, CROs, and vendors to ensure that overall project objectives are met.
Foster solid professional relationships with key opinion leaders and clinical site staff.
Partner with CRO(s) to ensure robust patient enrollment strategies are developed and carried out effectively and on time.
Partner with CRO(s) to ensure robust ongoing data monitoring strategies are developed and carried out effectively to ensure delivery of high‑quality data.
Proactively identify and manage study related risks.
Responsible for the development and management of clinical trial documents including protocols, case report forms (CRFs), consent documents, confidentiality agreements.
Review and manage study related plans, processes including investigator agreements (CTA), CRFs, CRF guidelines, statistical / pharmacokinetic analysis plans, monitoring plan, data management, and safety monitoring.
Review CRO(s) and vendor contracts/work orders and specifications to enable study objectives to be met.
Review and approve essential document packages to enable timely site activations.
Review pre‑study, study initiation, interim monitoring visit and at study closeout visit reports.
Provide close oversight on the findings on the monitoring reports and loop back with broader team to provide updates.
Direct investigator performance and adherence to protocol, and proactively address conduct issues and enrollment problems, as necessary.
Responsible for oversight of the maintenance of the TMF and completeness at the end of the study.
Perform periodic QC of the TMF.
Oversee the creation and execution of clinical trial activities in accordance with Good Clinical Practices (GCP).
Ensure compliance of clinical trials with national and international regulatory requirements and co‑monitor the assigned clinical trial following company SOPs.
Ensure the study is “inspection ready” always.
Responsible for oversight and coaching of functional activities of Clinical Research Associates and Clinical Trial Associates allocated to the project.
Perform other duties as assigned.
Experience, Education and Specialized Knowledge and Skills
Bachelor’s degree or equivalent in life science, nursing, pharmacy, medical laboratory technology, or other health/medical related area preferred.
10+ years of clinical project management experience in conducting international clinical trials in sponsor Pharma/Biotech organization.
A minimum of 5+ years of phase II and III combined experience required.
Strong understanding of the drug development process, ICH guidelines/GCP and specifically, each step within the clinical trial process.
Experience with budget forecasting and management.
Experience with clinical studies in oncology strongly preferred.
Ability to travel internationally to visit clinical sites and for study meetings (up to 20%).
Proven proficiency in overseeing large complex studies being managed in house and by a CRO.
Demonstrated ability to lead teams and work in a fast‑paced team environment.
Line management (direct reports) experience preferred.
Demonstrated ability to effectively delegate and manage others, as evidenced through either past people management or matrix management responsibilities.
Proven track record of building relationships with KOLs and site personnel.
Ability to successfully engage and work collaboratively with overseas clinical operations team members/colleagues.
Demonstrated ability to build and deliver on patient enrollment strategies.
Excellent interpersonal and decision‑making skills. Demonstrates innovation, possesses drive, energy, and enthusiasm to deliver the program objectives.
Demonstrated ability to comprehend and communicate complex scientific concepts and data.
Proficient in reviewing and assessing clinical data.
Possesses excellent planning, time management & coordination skills.
Demonstrated ability to problem solve and use clear judgment in relation to regulatory requirements, interactions with external parties, timelines, and complex clinical programs.
Proficient user of standard MS Office suite (e.g., Word, Excel), experience using electronic document management systems, and document review tools desirable.
Strong attention to detail, accuracy and confidentiality.
Must be able to effectively multi‑task and manage time‑sensitive and highly confidential documents.
Compensation The pay range for this role is $168,000–$198,000 annually. Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.
Contact Recruiting@smmttx.com
#J-18808-Ljbffr